Navigation Links
Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
Date:5/4/2009

-Preliminary Data from This Trial to be Presented at ASCO-

-First Phase II Trial in Bavituximab Cancer Program to Complete Patient Enrollment-

TUSTIN, Calif., May 4 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it has completed enrollment in its Phase II trial evaluating bavituximab in combination with docetaxel in advanced breast cancer patients. The planned 46 patients have been enrolled and are currently undergoing treatment and follow-up. The primary objective of the multi-center, open-label Phase II study is to assess the overall response rate to bavituximab and docetaxel. The company also announced that preliminary data from this trial has been accepted for oral presentation at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.

"Completion of patient enrollment in this Phase II study in advanced breast cancer patients represents a milestone for Peregrine's bavituximab cancer program, as this is the first of our three ongoing Phase II cancer trials to complete patient enrollment," said Steven W. King, president and CEO of Peregrine. "We will continue to assess patients in this study over the coming months and look forward to reporting updated preliminary results from the trial at the upcoming ASCO Annual Meeting."

In this trial's Simon two-stage design, 15 patients with advanced breast cancer were enrolled in the trial's first cohort. Ten of the 14 evaluable patients in this cohort demonstrated an objective tumor response according to RECIST criteria. These results compare favorably with historical response rates for docetaxel as solo therapy in advanced breast cancer patients and exceeded the pre-specified primary efficacy endpoint needed to expand enrollment in the trial. An additional 31 patients were then enrolled to achieve the planned study total of 46 patients overall.

Secondary obj
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
2. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
3. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
4. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
5. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
6. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
10. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
11. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)....J., Nov. 20 Soligenix, ...Company), formerly known as DOR BioPharma, Inc., a... that it has formed a consortium to develop thermo...apidly acting vaccines. Soligenix received a $9.4 ...gy and Infectious Diseases (NIAID), a division of ...
(Date:11/19/2009)...Nov. 19 In response to an ever-inc... illegal medicines, Operation Pangea II, involving... World Health Organization,s International Medical...o highlight the dangers of buying medicines online...n a series of arrests and the seizure of thousands...
(Date:11/19/2009)... Calif., Nov. 19 Alexza ...oday that its corporate presentation will be webca...h Care Conference on Wednesday, December 2, 2009 a...e webcast from The New York Palace Hotel in New Yo... President and CEO. ,, To access the live pre...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3CDCs National Center for Environmental Health Works with Thomson Reuters to Help Identify and Track Illnesses Related to Harmful Algal Blooms 50649 1CDCs National Center for Environmental Health Works with Thomson Reuters to Help Identify and Track Illnesses Related to Harmful Algal Blooms 50649 2Pennsylvania DEP Lehigh Valley Berks County Air Quality Partnership Urge Public Transit Use 50648 1Pennsylvania DEP Lehigh Valley Berks County Air Quality Partnership Urge Public Transit Use 50648 2Recoveries Secured by Philadelphia Personal Injury Law Firm Feldman Shepherd Rank among Top 50 in Pennsylvania and Top 100 in U S 50647 1Recoveries Secured by Philadelphia Personal Injury Law Firm Feldman Shepherd Rank among Top 50 in Pennsylvania and Top 100 in U S 50647 2Recoveries Secured by Philadelphia Personal Injury Law Firm Feldman Shepherd Rank among Top 50 in Pennsylvania and Top 100 in U S 50647 3
...March 20, 2007 -- Clinical studies have,shown (1) ... in,pediatric influenza patients being treated wit... for their influenza. Furthermore,recent data der...1999-2006 of over 101,000 influenza patients treat...s not taking Tamiflu have shown,that the Tamiflu t...
...--(BUSINESS WIRE)--Mar 22, 2007 - Aeolus,Pharmaceu...essful,completion of the analysis of results from ...10150 ("Study 102"). The clinical,direction for AE...e,most likely targets for an efficacy study as a p...lung cancer and/or head and neck,cancer and Amyotr...
Other Medicine Technology:New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 2New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 4Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 2Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 3Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 4
(Date:11/21/2009)... Linwood Group ask whether there is a se...ured? , London, UK (PRWEB...ith up to one in three of the adult UK population ...ping alcohol-related liver disease*, it is hardly ...ehabilitation programmes and residential centres f...
(Date:11/20/2009)...SHINGTON, Nov. 20 The ...s to modify health care reform legislation release... a health insurance individual coverage mandate. T...e mandate will minimize adverse selection stemming...cribed by the bill. ,, "The individual mandate ...
(Date:11/20/2009)... Senators and Congressmen in Competitive...r Health Care Vote , Wash...nd congressmen running for re-election next year i... Charlie Cook, may come to regret voting for House...cording to a breaking Zogby International/ O&rsquo...
(Date:11/20/2009)...T. LOUIS, Nov. 20 Cent...t it will present at the Bank of America Merrill L...-3, 2009, at the Crowne Plaza Hotel Times Square i...day, December 2nd at 8:30 a.m. Eastern Time. Inves...e, audio webcast of Centene,s presentation at: ht...
(Date:11/20/2009)...EGAS, Nov. 20 The follo...rector of the Nevada Health Care Association: ,...nds and thanks Senate Majority Leader Harry Reid f...er toward our goal of protecting every Nevada seni...and preserving the strength and viability of our s...
Breaking Medicine News(10 mins):Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
...ts in Jharkhand are refusing to stock the sexual e...berserk and create law and order problems." Viagra...waves worldwide for the treatment of erectile dysf...al secretary of the Jharkhand Chemist and Druggist...
...s are advising people to limit themselves to a cou...as the New Year approaches. A peg or two are capab...while excess consumption has the opposite effect, ..., the more alcohol one consumes, the greater the r...
...rld Health Organization has issued a statement, hi...d flu samples, collected from recent bird flu outb... the third bird flu related human death, by Beijin...efore a week, according to official reports. She i...
...arch was conducted by the American Researchers Ric...sity of California, Berkeley. He said that left si...an to identify varying shades of the same colour. ...ategorize the effect of the perceptible input to b...
...y was conducted by David Kallmes Neuroradiologist ...vertebroplasty) they experience reduced back pain....ive when compared to the other available new treat...ression fractures are present. These compressions ...
... King County Medical Examiner's report on 2004 dea...hs, fueled in large part by prescription painkille...ual report on deaths in King County, Statistics in...edical examiner of King County. Cocaine, morphi...
Other Medicine News:Health News:Colour Identification Lies Wholly On the Left Hemisphere of the Brain. 2Health News:Improved cure and activity level seen among patients treated by Vertebroplasty. 2Health News:Drug deaths in King County continue to go up 2
...A nonabsorbable knitted product for use in hernior... flexible and compliant material that affords exce...ty, along with maximal porosity for necessary tiss...nstructed from polyethylene terephthalate, the sam...
...The 800 Series KTP/YAG Surgical Laser System is de..., dual-wavelength system designed for urology, gyn...l surgery, neurosurgery, pulmonary surgery and gas...lly cuts, vaporizes and coagulates tissue with min...
...The Gemini is the newest addition to Laserscopes f... distinct wavelengths to choose from, 1064nm Nd:YA...ding non-invasive aesthetic laser market by pushin...ness while maintaining the safety and reliability ...
...The Venus-i Laser System is a new, portable, light...pplications in dermatology, cosmetic and plastic s... ideal laser for skin resurfacing, it is the small...s on the market. It provides an ideal treatment fo...
Medicine Products: